Radiosensitization of C3H mouse mammary tumours by a 2-nitroimidazole drug
- PMID: 4451633
- PMCID: PMC2009326
- DOI: 10.1038/bjc.1974.235
Radiosensitization of C3H mouse mammary tumours by a 2-nitroimidazole drug
Abstract
Local tumour control has been determined at 150 days after single doses of 240 kV x-rays given with or without 1 mg/g body weight of the hypoxic cell radiosensitizer Ro-07-0582. The dose required to control 50% of the tumours (TCD50) was reduced from 4380 to 2410 rad, yielding an enhancement ratio of 1·82 ± 0·07 s.e.mean. This compares favourably with the corresponding single dose gain factor for fast neutrons, which was about 1·7.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
